NLX-112, a Selective 5-HT1A Receptor Agonist, Upregulates GDNF and is Neuroprotective Against MPTP-Induced Nigrostriatal Degeneration in a Mouse Model of Parkinson’s Disease
- DOI
- 10.1021/acschemneuro.6c00251
- Published
- 2026-07-02
- Container
- ACS Chemical Neuroscience
- Publisher
- American Chemical Society (ACS)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1021/acschemneuro.6c00251,
title = {NLX-112, a
Selective 5-HT1A Receptor
Agonist, Upregulates GDNF and is Neuroprotective Against MPTP-Induced
Nigrostriatal Degeneration in a Mouse Model of Parkinson’s
Disease},
author = {William H. Powell and Lucy E. Annett and Ronan Depoortere and Adrian Newman-Tancredi and Mahmoud M. Iravani},
year = {2026},
journal = {ACS Chemical Neuroscience},
doi = {10.1021/acschemneuro.6c00251},
url = {https://doi.org/10.1021/acschemneuro.6c00251}
}RIS
TY - JOUR TI - NLX-112, a Selective 5-HT1A Receptor Agonist, Upregulates GDNF and is Neuroprotective Against MPTP-Induced Nigrostriatal Degeneration in a Mouse Model of Parkinson’s Disease AU - William H. Powell AU - Lucy E. Annett AU - Ronan Depoortere AU - Adrian Newman-Tancredi AU - Mahmoud M. Iravani PY - 2026 JO - ACS Chemical Neuroscience DO - 10.1021/acschemneuro.6c00251 UR - https://doi.org/10.1021/acschemneuro.6c00251 ER -
APA
Powell, W. H., Annett, L. E., Depoortere, R., Newman-Tancredi, A., & Iravani, M. M. (2026). NLX-112, a Selective 5-HT1A Receptor Agonist, Upregulates GDNF and is Neuroprotective Against MPTP-Induced Nigrostriatal Degeneration in a Mouse Model of Parkinson’s Disease. ACS Chemical Neuroscience. https://doi.org/10.1021/acschemneuro.6c00251
Source records
- crossref · retrieved 2026-09-27T06:26:24.576Z